LifeVantage Statistics
Total Valuation
LifeVantage has a market cap or net worth of $183.00 million. The enterprise value is $173.17 million.
Market Cap | 183.00M |
Enterprise Value | 173.17M |
Important Dates
The next estimated earnings date is Thursday, May 1, 2025, after market close.
Earnings Date | May 1, 2025 |
Ex-Dividend Date | Mar 3, 2025 |
Share Statistics
LifeVantage has 12.55 million shares outstanding. The number of shares has increased by 4.34% in one year.
Current Share Class | 12.55M |
Shares Outstanding | 12.55M |
Shares Change (YoY) | +4.34% |
Shares Change (QoQ) | +2.75% |
Owned by Insiders (%) | 19.32% |
Owned by Institutions (%) | 27.22% |
Float | 8.60M |
Valuation Ratios
The trailing PE ratio is 25.62 and the forward PE ratio is 13.96.
PE Ratio | 25.62 |
Forward PE | 13.96 |
PS Ratio | 0.83 |
Forward PS | 0.69 |
PB Ratio | 6.05 |
P/TBV Ratio | 6.14 |
P/FCF Ratio | 14.13 |
P/OCF Ratio | 12.73 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.24, with an EV/FCF ratio of 13.44.
EV / Earnings | 23.59 |
EV / Sales | 0.82 |
EV / EBITDA | 12.24 |
EV / EBIT | 15.97 |
EV / FCF | 13.44 |
Financial Position
The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.43.
Current Ratio | 1.66 |
Quick Ratio | 0.86 |
Debt / Equity | 0.43 |
Debt / EBITDA | 0.79 |
Debt / FCF | 0.99 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 25.67% and return on invested capital (ROIC) is 16.18%.
Return on Equity (ROE) | 25.67% |
Return on Assets (ROA) | 10.33% |
Return on Invested Capital (ROIC) | 16.18% |
Return on Capital Employed (ROCE) | 26.46% |
Revenue Per Employee | $955,640 |
Profits Per Employee | $33,063 |
Employee Count | 222 |
Asset Turnover | 3.23 |
Inventory Turnover | 2.64 |
Taxes
In the past 12 months, LifeVantage has paid $2.96 million in taxes.
Income Tax | 2.96M |
Effective Tax Rate | 28.74% |
Stock Price Statistics
The stock price has increased by +139.67% in the last 52 weeks. The beta is 0.77, so LifeVantage's price volatility has been lower than the market average.
Beta (5Y) | 0.77 |
52-Week Price Change | +139.67% |
50-Day Moving Average | 18.44 |
200-Day Moving Average | 13.20 |
Relative Strength Index (RSI) | 34.32 |
Average Volume (20 Days) | 172,720 |
Short Selling Information
The latest short interest is 1.60 million, so 12.71% of the outstanding shares have been sold short.
Short Interest | 1.60M |
Short Previous Month | 1.57M |
Short % of Shares Out | 12.71% |
Short % of Float | 18.55% |
Short Ratio (days to cover) | 8.16 |
Income Statement
In the last 12 months, LifeVantage had revenue of $212.15 million and earned $7.34 million in profits. Earnings per share was $0.56.
Revenue | 212.15M |
Gross Profit | 169.27M |
Operating Income | 10.84M |
Pretax Income | 4.19M |
Net Income | 7.34M |
EBITDA | 14.15M |
EBIT | 10.84M |
Earnings Per Share (EPS) | $0.56 |
Balance Sheet
The company has $21.60 million in cash and $12.77 million in debt, giving a net cash position of $8.83 million or $0.70 per share.
Cash & Cash Equivalents | 21.60M |
Total Debt | 12.77M |
Net Cash | 8.83M |
Net Cash Per Share | $0.70 |
Equity (Book Value) | 29.89M |
Book Value Per Share | 2.38 |
Working Capital | 18.24M |
Cash Flow
In the last 12 months, operating cash flow was $14.29 million and capital expenditures -$1.41 million, giving a free cash flow of $12.88 million.
Operating Cash Flow | 14.29M |
Capital Expenditures | -1.41M |
Free Cash Flow | 12.88M |
FCF Per Share | $1.03 |
Margins
Gross margin is 79.79%, with operating and profit margins of 5.11% and 3.46%.
Gross Margin | 79.79% |
Operating Margin | 5.11% |
Pretax Margin | 4.86% |
Profit Margin | 3.46% |
EBITDA Margin | 6.67% |
EBIT Margin | 5.11% |
FCF Margin | 6.07% |
Dividends & Yields
This stock pays an annual dividend of $0.16, which amounts to a dividend yield of 1.09%.
Dividend Per Share | $0.16 |
Dividend Yield | 1.09% |
Dividend Growth (YoY) | -70.37% |
Years of Dividend Growth | n/a |
Payout Ratio | 28.43% |
Buyback Yield | -4.34% |
Shareholder Yield | -3.25% |
Earnings Yield | 4.03% |
FCF Yield | 7.08% |
Analyst Forecast
The average price target for LifeVantage is $30.50, which is 109.19% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $30.50 |
Price Target Difference | 109.19% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on October 19, 2015. It was a reverse split with a ratio of 0.1428571:1.
Last Split Date | Oct 19, 2015 |
Split Type | Reverse |
Split Ratio | 0.1428571:1 |
Scores
LifeVantage has an Altman Z-Score of 3.51 and a Piotroski F-Score of 6.
Altman Z-Score | 3.51 |
Piotroski F-Score | 6 |